Meta-analysis of the safety of polysaccharide iron complex versus ferrous sulfate in the treatment of anemia during pregnancy / 中国药房
China Pharmacy
;
(12): 1627-1631, 2023.
Article
in Chinese
| WPRIM
| ID: wpr-977854
ABSTRACT
OBJECTIVE To compare the safety of polysaccharide iron complex and ferrous sulfate in the treatment of anemia during pregnancy. METHODS Retrieved from Cochrane Library, PubMed, Embase, SinoMed, CNKI, VIP and Wanfang database, randomized controlled trials (RCTs) about polysaccharide iron complex (trial group) versus ferrous sulfate (control group) in the treatment of anemia during pregnancy were collected from the inception to May 20th, 2022. After literature screening, data extraction and quality evaluation, meta-analysis, sensitivity analysis and publication bias analysis were conducted with RevMan 5.3 software. RESULTS A total of 13 RCTs were included, with a total of 1 318 patients. Results of meta-analysis showed that the total incidence of adverse drug reactions (ADR) [RR=0.11, 95%CI (0.06, 0.18), P<0 000 01], gastrointestinal adverse reactions [RR=0.08, 95%CI (0.05, 0.12), P<0.000 01], anorexia and nausea [RR=0.21, 95%CI (0.09, 0.54), P= 0.001], abdominal pain [RR=0.18, 95%CI (0.04, 0.78), P=0.02], diarrhea [RR=0.18, 95%CI (0.04, 0.79), P=0.02], vomiting [RR=0.24, 95%CI (0.06, 0.89), P=0.03] and gingival melanosis [RR=0.09, 95%CI (0.03, 0.28), P<0.000 1] in the trial group were all significantly lower than the control group. The results of sensitivity analysis showed that the conclusions obtained in this study were relatively robust. The results of publication bias analysis indicated that there was a high possibility of publication bias in this study. CONCLUSIONS The polysaccharide iron complex is safer than ferrous sulfate for treatment of anemia during pregnancy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Systematic reviews
Language:
Chinese
Journal:
China Pharmacy
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS